asa glp 1 guidelines 2025 Perioperative management of patients taking glucagon-like peptide receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement asa glp-1 agonist guidelines Ten

Effects of vitamin C on the outcome of in vitro fertilization-embryo transfer in endometriosis: A randomized controlled study

It should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis, as it is not a substitute for insulin in these conditions

This is especially concerning for: people with existing gut problems people with gastritis or ulcers people who already struggle with low appetite or nutrient deficiencies The Less Discussed Metabolic Risk When food intake drops too aggressively, several things can happen metabolically: protein intake becomes inadequate micronutrient intake drops muscle mass can decline resting metabolic rate may slow over time fatigue increases hormonal balance becomes more fragile This matters deeply for long-term weight maintenance

A., Hanyaloglu, A

The absolute weight loss associated with semaglutide use is up to 4.6 kg and 6.5 kg at doses of 0.5 mg and 1.0 mg respectively over 40 weeks

Z., Zheng, S